HCW Biologics Inc.
HCWB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $7 | $0 |
| % Growth | -9.7% | -57.7% | – | – |
| Cost of Goods Sold | $2 | $2 | $4 | $1 |
| Gross Profit | $1 | $1 | $3 | -$1 |
| % Margin | 37.4% | 19.7% | 38.5% | – |
| R&D Expenses | $6 | $8 | $9 | $8 |
| G&A Expenses | $22 | $13 | $8 | $0 |
| SG&A Expenses | $22 | $13 | $8 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $6 | $0 | $0 |
| Operating Expenses | $30 | $26 | $18 | $13 |
| Operating Income | -$29 | -$26 | -$15 | -$13 |
| % Margin | -1,148.5% | -905% | -224.3% | – |
| Other Income/Exp. Net | -$1 | $1 | $0 | $1 |
| Pre-Tax Income | -$30 | -$25 | -$15 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$30 | -$25 | -$15 | -$13 |
| % Margin | -1,169.7% | -879.5% | -221.7% | – |
| EPS | -0.77 | -0.7 | -0.41 | -0.35 |
| % Growth | -10% | -70.7% | -17.1% | – |
| EPS Diluted | -0.77 | -0.7 | -0.41 | -0.35 |
| Weighted Avg Shares Out | 39 | 36 | 36 | 36 |
| Weighted Avg Shares Out Dil | 39 | 36 | 36 | 36 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$28 | -$24 | -$14 | -$12 |
| % Margin | -1,078.4% | -829.6% | -209.1% | – |